» Articles » PMID: 1260722

Immature (malignant) Teratoma of the Ovary: a Clinical and Pathologic Study of 58 Cases

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 1976 May 1
PMID 1260722
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Fifty-eight immature ovarian teratomas were studied. Neoplams with other germ cell elements (endodermal sinus tumor, choriocarcinoma, and dysgerminoma) were excluded so that the clinical and pathologic features of "pure" immature teratomas could be defined and correlated with the prognosis. The primary tumors and their metastatic growths were graded from 0 to 3. Forty were stage I; nine, stage II; and nine, stage III. The size and stage of teratomas were related to survival, but it was the grade of the primary tumor that best determined the likelihood of extraovarian spread, and it was the grade of the metastases that related best to the subsequent course. Actuarial survival was 63% at 5 years and also at 10 years. Regardless of the grade of the primary tumor, only one of six with grade 0 metastases progressed, and that neoplasms may not have been adequately sampled. Two of five neoplasms having grade 1 metastases did not progress, and two of six patients with grade 2 metastatic growths were living after relatively long intervals. All seven patients with grade 3 metastases died with tumor, none surviving more than 2.1 years. Survival of patients with grade 1, 2, and 3 neoplasms was 81, 60, and 30% respectively. The importance of adequate sampling of primary tumor and metastases for estimating prognosis and determining therapy is stressed.

Citing Articles

Management strategy for children with ovarian immature teratoma: results from a tertiary pediatric oncology center.

Ahmed G, Khalil S, Elshafiey M, Abdelfattah N, Eid M, Zakaria A World J Surg Oncol. 2024; 22(1):176.

PMID: 38965563 PMC: 11223275. DOI: 10.1186/s12957-024-03452-z.


Exploring the role of SOX 2 and OCT 4 in the pathogenesis of gliomatosis peritonei: the clinicopathological profile of eleven cases.

Rathore R, Kaul S, Sharma J, Mathur S J Turk Ger Gynecol Assoc. 2024; 25(2):66-73.

PMID: 38867687 PMC: 11576629. DOI: 10.4274/jtgga.galenos.2024.2023-9-4.


Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy.

Marino G, Grassi T, De Ponti E, Negri S, Testa F, Giuliani D Front Oncol. 2024; 14:1330481.

PMID: 38371620 PMC: 10869612. DOI: 10.3389/fonc.2024.1330481.


The Role of Early and Delayed Surgery for Infants with Congenital Brain Tumors.

Lee J, Lee J, Kim K, Park S, Koh E, Kim S Cancer Res Treat. 2024; 56(3):909-919.

PMID: 38186242 PMC: 11261196. DOI: 10.4143/crt.2023.1174.


Characterization of immature ovarian teratomas through single-cell transcriptome.

Cao M, Deng Y, Deng Y, Wu J, Yang C, Wang Z Front Immunol. 2023; 14:1131814.

PMID: 36936909 PMC: 10020330. DOI: 10.3389/fimmu.2023.1131814.